{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:55:51Z","timestamp":1793051751504,"version":"4.5.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/aog.0b013e3181c52616","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T08:46:47Z","timestamp":1261039607000},"page":"109-115","source":"Crossref","is-referenced-by-count":110,"title":["Acetaminophen Use in Pregnancy and Risk of Birth Defects"],"prefix":"10.1097","volume":"115","author":[{"given":"Marcia L.","family":"Feldkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Krikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo D.","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210126","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/0002-9378(86)90173-0","article-title":"Acetaminophen pharmacokinetics: comparison between pregnant and nonpregnant women.","volume":"155","author":"Rayburn","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"R2-18-20210126","first-page":"43","article-title":"Goodman & Gilman: the pharmacological basis of therapeutics.","author":"Nies","year":"1996"},{"key":"R3-18-20210126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2007-993879","article-title":"Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy. EuroMap Study Group.","volume":"16","author":"Thulstrup","year":"1999","journal-title":"Am J Perinatol"},{"key":"R4-18-20210126","first-page":"451","article-title":"First-trimester drug use and congenital disorders.","volume":"65","author":"Aselton","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R5-18-20210126","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"Use of over-the-counter medications during pregnancy.","volume":"193","author":"Werler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R6-18-20210126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ajog.2007.08.040","article-title":"Acetaminophen use during pregnancy: effects on risk for congenital abnormalities.","volume":"198","author":"Rebordosa","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R7-18-20210126","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/bdra.20369","article-title":"High fever-related maternal diseases as possible causes of multiple congential abnormalities: a population-based case-control study.","volume":"79","author":"Ceizel","year":"2007","journal-title":"Birth Defects Res Clin Mol Teratol"},{"key":"R8-18-20210126","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","article-title":"Maternal medications and environmental exposures as risk factors for gastroschisis.","volume":"54","author":"Torfs","year":"1996","journal-title":"Teratology"},{"key":"R9-18-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/155.1.26","article-title":"Maternal medication use and risks of gastroschisis and small intestinal atresia.","volume":"155","author":"Werler","year":"2002","journal-title":"Am J Epidemiol"},{"key":"R10-18-20210126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/bdra.20005","article-title":"Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects.","volume":"70","author":"Cleves","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"Suppl 1","key":"R11-18-20210126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/phr\/116.S1.32","article-title":"The National Birth Defects Prevention Study.","volume":"116","author":"Yoon","year":"2001","journal-title":"Public Health Rep"},{"key":"R12-18-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study.","volume":"67","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R13-18-20210126","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/bdra.20403","article-title":"Seeking causes: classifying and evaluating congenital heart defects in etiologic studies.","volume":"79","author":"Botto","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R14-18-20210126","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/bdra.20277","article-title":"Review: hyperthermia and fever during pregnancy.","volume":"79","author":"Edwards","year":"2006","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R15-18-20210126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-9926(199811)58:5<209::AID-TERA8>3.0.CO;2-Q","article-title":"Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans.","volume":"58","author":"Graham","year":"1998","journal-title":"Teratology"},{"key":"R16-18-20210126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001648-200207000-00019","article-title":"Maternal fever, multivitamin use, and selected birth defects: evidence of interaction:","volume":"13","author":"Botto","year":"2002","journal-title":"Epidemiol"},{"key":"R17-18-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9926(199801)57:1<1::AID-TERA1>3.0.CO;2-6","article-title":"Maternal illness, including fever, and medication use as risk factors for neural tube defects.","volume":"57","author":"Shaw","year":"1998","journal-title":"Teratology"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201001000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:23Z","timestamp":1786039763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201001000-00018"}},"subtitle":["Findings From the National Birth Defects Prevention Study"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181c52616","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}